Ahmed Salleh Barefah MBBS, ABIM, FRCPC, ABIM, FRCPC
Consultant in Internal medicine, Hematology, Malignant hematology & lymphoma
Internal Medicine Department
Years of Experience: 14
Education
Medical School
2009
Bachelor’s Degree in Medicine and Surgery
King Abdulaziz University, Jeddah, KSA
Fellowships
Fellowship
2015
Fellowship of Royal College of Physicians Canada (FRCPC)
Fellowship
2018
McMaster University, Canada
Canadian Fellowship in Malignant Hematology, Lymphoma
Membership
- President of the Saudi Society of Hematology
- Member of the Saudi Society for Blood and Marrow Transplanation
- Member of the Saudi Lymphoma group
- Member of the Saudi Myeloma group
- Member of the American Society of Hematology
- Member of the European Hematology Association
License
Work Experience
2023 – Present
Consultant in Internal medicine, Hematology, Malignant hematology & lymphoma
International Medical Center, Jeddah, Saudi Arabia
2011 – 2018
Residency and Fellowship in Internal Medicine, Hematology and Malignant Hematology and Lymphoma
McMaster University, Canada
2014
American Board of Internal Medicine
2014
Canadian Board of Internal Medicine
2016
Canadian Board of Hematology
2016
American Board of Hematology
2009 – 2010
Resident, Internal Medicine
King Abdulaziz University, Jeddah, KSA
2018 – present
Assistant Professor and consultant in Hematology
King Abdulaziz University Hospital, Jeddah, KSA
Achievements & Career Highlights
- Associate Professor of Hematology, King Abdulaziz University
- President of The Saudi Society of Hematology
- Head of the hematology research unit at King Fahd medical research center
- (MBBS) King Abdulaziz University, Jeddah, Saudi Arabia 2009 (Hon)
- (ABIM) American Board of Internal Medicine 2014.
- (FRCPC) Canadian Board in Internal Medicine, McMaster University 2011 - 2014.
- (ABIM) American Board in Hematology 2016.
- (FRCPC) Canadian Board in Hematology, McMaster University 2014 - 2016.
- Malignant Hematology Fellowship, McMaster University, Canada. 2016 – 2018.
- Independent practice as an adult hematologist and BMT at Juravinski cancer center, McMaster University, Canada. 2017-2018.
Publications
- Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine. Barefah AS, Radhwi OO, Alamri SS, Alahwal HM, Denetiu I, Almohammadi AT, Bahashwan SM, Qari MH, Algaissi A, Alamer E, Alhazmi A, Abuzenadah AM, Nasraldeen WH, Alzahrani SH, Hashem AM. Low clinical utility of testing for anti-platelet factor 4 in asymptomatic individuals after ChAdOx1 nCoV-19 vaccine. Int J Lab Hematol. 2022 Apr;44(2):424-429. doi: 10.1111/ijlh.13774. Epub 2021 Nov 30. PMID: 34850575.
- TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia. Alkhatabi H, Yasin EB, Mirza Z, Alserihi R, Felimban R, Elaimi A, Shaabad M, Alharbi L, Ahmed H, Alameer AM, Mathkoor AE, Barefah AS. TP53 Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia. Diagnostics (Basel). 2022 Mar 16;12(3):724. doi: 10.3390/diagnostics12030724. PMID: 35328276; PMCID: PMC8946951.
- A Smart Chatbot for Interactive Management in Beta Thalassemia Patients. Alturaiki AM, Banjar HR, Barefah AS, Alnajjar SA, Hindawi S. A Smart Chatbot for Interactive Management in Beta Thalassemia Patients. Int J Telemed Appl. 2022 May 11;2022:9734518. doi: 10.1155/2022/9734518. PMID: 35601050; PMCID: PMC9117039.
- Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. Radhwi OO, Jan H, Waheeb A, Alamri SS, Alahwal HM, Denetiu I, Almanzlawey A, Al-Marzouki AF, Almohammadi AT, Bahashwan SM, Barefah AS, Qari MH, Abuzenadah AM, Hashem AM. Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies. Vaccines (Basel). 2022 Jan 20;10(2):151. doi: 10.3390/vaccines10020151. PMID: 35214610; PMCID: PMC8877446.
- Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms. Yasin EB, Alserihi R, Alkhatabi H, Qutob HMH, Qahwaji R, Kattan SW, Gholam KA, Hussein E, Barefah AS, Alghuthami ME, Abuzenadah A. Methylation of the suppressor of Cytokine Signaling 1 Gene (SOCS1) in Philadelphia-negative myeloproliferative neoplasms. Eur Rev Med Pharmacol Sci. 2022 Nov;26(22):8451-8458. doi: 10.26355/eurrev_202211_30381. PMID: 36459028.
- Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management. Bahashwan SM, Radhwi OO, Alahwal HM, Almohammadi AT, Barefah AS, Daous YM, Alghamdi FA. Primary Central Nervous System Burkitt Lymphoma, Presenting with Long-Term Fluctuating Level of Consciousness: A Case Report and Literature Review on Challenges in Diagnosis and Management. Am J Case Rep. 2022 Jun 21;23:e936401. doi: 10.12659/AJCR.936401. PMID: 35727738; PMCID: PMC9235913.
- COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia. Jan H, Waheeb A, AlAhwal H, Almohammadi A, Al-Marzouki A, Barefah A, Bahashawan S, Radhwi O. COVID-19 Vaccine Perception and Hesitancy Among Patients With Sickle Cell Disease in the Western Region of Saudi Arabia. Cureus. 2022 Jan 8;14(1):e21026. doi: 10.7759/cureus.21026. PMID: 35154996; PMCID: PMC8820497.
- Reticulocyte Hemoglobin-Equivalent Potentially Detects, Diagnoses and Discriminates between Stages of Iron Deficiency with High Sensitivity and Specificity. Almashjary MN, Barefah AS, Bahashwan S, Ashankyty I, ElFayoumi R, Alzahrani M, Assaqaf DM, Aljabri RS, Aljohani AY, Muslim R, Baawad SA, Bawazir WM, Alharthy SA. Reticulocyte Hemoglobin-Equivalent Potentially Detects, Diagnoses and Discriminates between Stages of Iron Deficiency with High Sensitivity and Specificity. J Clin Med. 2022 Sep 26;11(19):5675. doi: 10.3390/jcm11195675. PMID: 36233545; PMCID: PMC9572493.
- Lack of Evidence on Association between Iron Deficiency and COVID-19 Vaccine-Induced Neutralizing Humoral Immunity. Faizo AA, Bawazir AA, Almashjary MN, Hassan AM, Qashqari FS, Barefah AS, El-Kafrawy SA, Alandijany TA, Azhar EI. Lack of Evidence on Association between Iron Deficiency and COVID-19 Vaccine-Induced Neutralizing Humoral Immunity. Vaccines (Basel). 2023 Feb 1;11(2):327. doi: 10.3390/vaccines11020327. PMID: 36851205; PMCID: PMC9965425.
-
Alelyani RH, Alghamdi AH, Almughamisi TA, Alshareef AM, Kadasa AN, Alrajhi AM, Alburayk AK, Barefah AS, Radhwi OO, Almohammadi AT, Bahashawan SM, AlAhwal HM. Incidence and Risk Factors of Infections Among Diffuse Large B-cell Lymphoma and Classical Hodgkin's Lymphoma Patients in a Tertiary Care Center in Saudi Arabia: A Retrospective Cohort Study. Cureus. 2023 Mar 9;15(3):e35922. doi: 10.7759/cureus.35922. PMID: 36911585; PMCID: PMC9996399.
-
Alsilmi R, Alghamdi S, Alghamdi S, Alshahrani R, Alyoubi A, Almassari O, Alshaikhi M, Barefah A, Ajlan A, Eskander A, Jabali F. Chest computed tomographic findings in patients with sickle cell disease–related acute chest syndrome: A retrospective study.
-
Alkhamesi S, Almohammadi A, Alahwal H, Barefah A, Bahashwan S, Radhwi O. Quality of systematic reviews/meta-analyses in coronavirus disease 2019 and venous thromboembolism: An analysis using a measurement tool to assess systematic reviews-2. Journal of Applied Hematology. 2022 Oct 1;13(4):222.
-
Bahashwan SM, Alahwal HM, Almohammadi AT, Radhwi OO, Khan SA, Barefah AS. Impact of COVID-19 Pandemic on Treatment Decisions of Patients Treated by Hematologists in Saudi Arabia. Journal of Applied Hematology. 2023 Jan 1;14(1):7.
-
Web-based expert system with quick response code for beta-thalassemia management.
Banjar HR, Zaher GF, Almutiry HS, Alshamarni ASA, Almouhana GI, Alahwal HM, Bahashwan S, Barefah AS, Alnajjar SA, Alharbi HM. Web-based expert system with quick response code for beta-thalassemia management. Health Informatics J. 2021 Jan-Mar;27(1):1460458221989397. doi: 10.1177/1460458221989397. PMID: 33570008.
-
The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding.
Almakadi M, Sheasgreen C, Barefah A, Lu L, Kumar Tyagi N, Mazzetti G, Crabbe L, Yuan Y, Crowther M, Leontiadis G. The risk of venous thromboembolism in patients with clinically overt gastrointestinal bleeding. Am J Hematol. 2018 Feb;93(2):E42-E45. doi: 10.1002/ajh.24967. Epub 2017 Nov 22. PMID: 29119605.
-
Tumour lysis syndrome in a patient with undifferentiated endometrial stromal sarcoma.
Ahmed Z, Barefah A, Wasi P, Jones G, Ramsay J. Tumour lysis syndrome in a patient with undifferentiated endometrial stromal sarcoma. Gynecol Oncol Rep. 2019 Feb 15;28:41-43. doi: 10.1016/j.gore.2019.02.006. PMID: 30834285; PMCID: PMC6384315.
-
Alzahrani M, Al-Mansour MM, Apostolidis J, Barefah A, Dada R, Alhejazi A, Alayed Y, Motabi I, Radwi M, Al-Hashmi H. Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic. Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20. PMID: 32952517; PMCID: PMC7485653.
-
Resident reflections on end-of-life education: a mixed-methods study of the 3 Wishes Project.
Centofanti J, Swinton M, Dionne J, Barefah A, Boyle A, Woods A, Shears M, Heels-Ansdell D, Cook D. Resident reflections on end-of-life education: a mixed-methods study of the 3 Wishes Project. BMJ Open. 2016 Mar 31;6(3):e010626. doi: 10.1136/bmjopen-2015-010626. PMID: 27033962; PMCID: PMC4823392.
Get the Right Care For You & Your Family
